These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2255691)

  • 61. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical study of a 6-month chemotherapy regimen in the treatment of pulmonary tuberculosis. Results approximately 2 years after completion of chemotherapy].
    Fortic B
    Plucne Bolesti; 1989; 41(1-2):46-57. PubMed ID: 2798572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis].
    Kartoziia LS
    Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373
    [No Abstract]   [Full Text] [Related]  

  • 64. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Survey of the initial treatment of pulmonary tuberculosis in West Germany. A study by the German Central Committee for the Prevention of Tuberculosis].
    Zierski M; Hoffmann O; Bornhardt E
    Pneumologie; 1989 Dec; 43(12):691-702. PubMed ID: 2622876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
    Vakhidova GA; Vasil'eva FR; Kurbanova RR; Stepanenko RN; Ubaĭdullaev AM
    Probl Tuberk; 1990; (3):16-8. PubMed ID: 2367502
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Intermittent polychemotherapy of patients with chronic destructive pulmonary tuberculosis with associated diabetes mellitus].
    Cheren'ko SA
    Probl Tuberk; 1989; (8):48-50. PubMed ID: 2813313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis].
    Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP
    Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714
    [No Abstract]   [Full Text] [Related]  

  • 72. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
    Mar'iandyshev AO; Klinberg NM; Shonbina AI; Moroz MI
    Probl Tuberk; 1997; (4):19-21. PubMed ID: 9333808
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Intensive chemotherapy regimens in pulmonary tuberculosis with concomitant diabetes mellitus].
    Cheren'ko SA
    Vrach Delo; 1990 Sep; (9):87-8. PubMed ID: 2284784
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Attention on establishing retreatment regimen of pulmonary tuberculosis].
    Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):401-2. PubMed ID: 17673005
    [No Abstract]   [Full Text] [Related]  

  • 75. [Controlled trial of 2-4 month and 2-6 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A joint study of the British Medical Research Council and Singapore].
    Poh SC
    Bull Int Union Tuberc; 1978 Dec; 53(4):258-9. PubMed ID: 387139
    [No Abstract]   [Full Text] [Related]  

  • 76. [Rapid combined chemotherapy of destructive pulmonary tuberculosis].
    Bondarev IM; Sokolova GB
    Probl Tuberk; 1979 Nov; (11):15-20. PubMed ID: 530962
    [No Abstract]   [Full Text] [Related]  

  • 77. Side effects of short course tuberculosis chemotherapy.
    Simon GK; Lye MS; Ahmad N
    Med J Malaysia; 1991 Mar; 46(1):88-94. PubMed ID: 1836044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Long-term results of chemotherapy of newly detected patients with destructive pulmonary tuberculosis].
    Roslik SM; Pashkov IuN; Matveeva SL; Iushchenko LP; Gerasimova TG; Liudvichek IA; Iakovleva LM; Stepanenko AL; Pankova LI
    Probl Tuberk; 1991; (2):33-6. PubMed ID: 2034639
    [No Abstract]   [Full Text] [Related]  

  • 79. [Radioisotope scanning of the lungs of patients with destructive pulmonary tuberculosis during treatment with antibacterial drugs and lidase].
    Grigaliunas AP
    Probl Tuberk; 1975; (5):45-7. PubMed ID: 1144343
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis.
    Khomenko AG; Averbach MM; Litvinov VI; Gergert VJ; Chukanov VI
    Bull World Health Organ; 1984; 62(5):763-71. PubMed ID: 6391716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.